PTPA: Protein Phosphatase 2 Phosphatase Activator

A key regulator of PP2A phosphatase activity, implicated in cancer and neurological disorders.

Gene Information Card

Symbol PTPA
Full Name Protein Phosphatase 2 Phosphatase Activator
Gene Type Protein coding
Chromosomal Location 9q34.3
NCBI Gene ID 5524 ncbi.nlm.nih.gov/gene/5524
Ensembl ID ENSG00000136869
UniProt ID Q15257
OMIM ID 600756
HGNC ID 9308
Aliases PPP2R4, PP2A, PR53

Description

PTPA (Protein Phosphatase 2 Phosphatase Activator) encodes a regulatory subunit of protein phosphatase 2A (PP2A). The encoded protein activates the latent form of PP2A by converting the inactive dimeric form to the active heterotrimeric form. It also possesses peptidyl-prolyl cis-trans isomerase activity. PTPA is essential for PP2A holoenzyme assembly and function, impacting cell cycle regulation, signal transduction, and apoptosis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (multiple types) Dysregulation of PP2A activity via PTPA mutations or altered expression leads to aberrant cell proliferation and survival. COSMIC; PMID: 23583978
Neurodevelopmental disorders Loss-of-function variants in PTPA impair PP2A activation, affecting neuronal signaling and development. ClinVar; PMID: 31036916
Alzheimer's disease Reduced PTPA expression correlates with decreased PP2A activity and increased tau phosphorylation. PMID: 21832049

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Medium
Liver 6.1 Low
Kidney 9.7 Medium
Testis 15.2 High
Cell Line Expression
Cell Line nTPM Notes
HEK293 14.8 High expression
HeLa 11.2 Medium expression
K562 9.5 Medium expression
MCF7 7.3 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.287G>A (p.Arg96His) Missense <0.1% Reduced PP2A activation; associated with neurodevelopmental delay (ClinVar)
c.1A>G (p.Met1?) Start loss <0.1% Loss of protein expression; likely pathogenic (ClinVar)
c.511C>T (p.Arg171Trp) Missense <0.1% Impaired isomerase activity; reported in cancer (COSMIC)
Mutation functional classification

Loss of Function (LOF)

Missense and truncating mutations that reduce or abolish PTPA's ability to activate PP2A, leading to decreased PP2A activity.

Gain of Function (GOF)

Not well documented; no clear gain-of-function mutations reported in major databases.

Dominant Negative (DN)

Some missense variants (e.g., p.Arg96His) may interfere with wild-type PTPA function in a dominant-negative manner, though evidence is limited.

Gene Ontology (GO)

• protein phosphatase type 2A regulator activity (GO:0008601) peptidyl-prolyl cis-trans isomerase activity (GO:0003755)
protein kinase binding (GO:0019901) • regulation of phosphoprotein phosphatase activity (GO:0043666)
cytosol (GO:0005829) nucleus (GO:0005634)

Pathways

REACT: R-HSA-163615 - PP2A-mediated dephosphorylation
REACT: R-HSA-69278 - Cell Cycle
Mitotic
REACT: R-HSA-1257604 - PIP3 activates AKT signaling

Protein Summary

PTPA (PPP2R4) is a 370-amino acid protein that functions as a specific activator of protein phosphatase 2A (PP2A). It binds to the PP2A dimer (catalytic and scaffold subunits) and induces a conformational change that allows the regulatory subunit to bind, forming the active trimeric holoenzyme. PTPA also exhibits peptidyl-prolyl cis-trans isomerase activity, which is required for its PP2A activation function. The protein is widely expressed, with highest levels in brain and testis. Mutations in PTPA are associated with neurodevelopmental disorders and cancer.

Related Products

Product name Cat.No. Species Gene ID
PTPA Knockout HEK293 Cell Line EDJ-KQ3709 Human 5524 Details Get a Quote
PTPA Knockout A-549 Cell Line EDJ-KQ24366 Human 5524 Details Get a Quote
PTPA Knockout HCT 116 Cell Line EDJ-KQ25738 Human 5524 Details Get a Quote
PTPA Knockout HeLa Cell Line EDJ-KQ25739 Human 5524 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: